Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Menin Inhibitor KO-539 in Combination with Venetoclax

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement